The government’s measles-rubella vaccination campaign has come at a crucial time. Faced with the threat of a possible outbreak, it is encouraging to see that the response has been swift, visible, and effective.
This is the kind of prompt action which demonstrates how, when public health interventions are timely and accessible, they do more than mitigate risk; they rebuild public trust, which is arguably as critical as the vaccine itself.
It is high time we recognize vaccination for what it is -- not just a medical tool, but a public good.
In a densely populated country like Bangladesh, there is virtually no room for complacency. A single gap in coverage can quickly translate into a disastrous outbreak, placing the most vulnerable -- children -- at immediate risk.
Preventive care, therefore, cannot be treated as optional or episodic; it must remain continuous and comprehensive.
What this ongoing campaign highlights is the importance of staying ahead rather than reacting after the fact -- an approach that we have historically been far too familiar with.
It cannot be reiterated enough: The cost of prevention is always lower than the cost of containment, both in economic terms and in human lives.
Ensuring that vaccination programs remain robust, well-funded, and far-reaching is essential to maintaining this advantage.
At the same time, the success of such initiatives must be sustained: Continued awareness, consistent outreach, and equitable access are necessary to ensure that no one in the community is left behind.
The resolution this initiative will bring today should not be a fleeting outcome of crisis response, but a lasting feature of a healthcare system that prioritizes preparedness.
The takeaway from this should be clear: Vaccination is not simply about addressing immediate healthcare fears -- it is about building a future where such fears have neither room nor reason to take hold.



